期刊文献+

磁共振成像检查中不同b值弥散加权成像对前列腺癌的应用价值 被引量:18

The application value of different b value diffusion-weighted imaging of prostate cancer in MRI examination
下载PDF
导出
摘要 目的:探讨T2WI及不同b值的弥散加权成像(DWI)技术对前列腺癌的诊断价值。方法:回顾性分析29例经穿刺活检证实的前列腺癌患者的磁共振成像(MRI)资料,29例前列腺癌患者均行轴位T2WI及中b值(b=1000 s/mm^2)DWI扫描,其中21例同时行超高b值(b=2500 s/mm^2)DWI扫描,由2位MR医师分别阅片并协商判定T2WI和不同b值DWI的诊断结果。结果:超高b值(b=2 500 s/mm^2)DWI的前列腺癌确诊率为80.95%,中b值(b=1000 s/mm^2)DWI的确诊率为72.41%,超高b值DWI的前列腺癌确诊率最高。结论:超高b值DWI能够提高前列腺癌检出率及诊断准确性,具有良好的临床应用价值。 Objective:To explore the diagnostic value of diffusion-weighted imaging (DWI) technique for two factors of T2WI and different b value in the diagnosis of prostate cancer. Methods: 29 cases of prostate cancer confirmed by biopsy were analyzed retrospectively, who underwent axial T2WI and DWI scanning for b value (1000 s/mm2). Of them, 21 cases performed DWI scanning for ultra high b value(2500 s/mm2). 2 magnetic resonance(MR) doctors interpreted the imagine separately and consulted together to determine T2WI value and diagnostic result of DWI in different b value.Results: The diagnosis rate of DWI scanning for prostate cancer in ultra high b value (2500 s/mm2) was 80.95%. The diagnosis rate of DWI scanning in b value (1000 s/mm2) was 72.41%. The diagnosis rate of DWI scanning in ultra high b value (2500 s/mm2) was the highest.Conclusion: DWI scanning in ultra high b value (2500 s/mm2) can improve the detection rate and accuracy of diagnosis for prostate cancer. It has a good value for clinical application.
出处 《中国医学装备》 2016年第6期47-50,共4页 China Medical Equipment
基金 全军科技攻关项目(06G034)"中药与现代技术优化对恶性肿瘤的防治研究"
关键词 前列腺癌 核磁共振 弥散加权成像 Prostatic cancer Nuclear magnetic resonance Diffusion weighted imaging
  • 相关文献

参考文献10

  • 1杨宗珂,王德林,杨研,汪伟,刘登,刘遇春,熊世华.前列腺特异性抗原及其相关指标在前列腺癌鉴别诊断中的应用价值[J].中国医学装备,2015,12(12):31-35. 被引量:11
  • 2Kim CK,Park BK,Kim B.Diffusion-weightedMRI at 3T for the evaluation of prostate cancer[J].Am J Roentgenol,2010,194(6):1461-1469.
  • 3Metens T,Miranda D,Absil J,et al.What is the optimal b value in diffusion-weighted MRimaging to depict prostate cancer at 3T[J].EurRadiol,2012,22(3):703-709.
  • 4Katahira K,Takahara T,Kwee TC,et al.Ultrahigh-b-value diffusion-weighted MR imagingfor the detection of prostate cancer:evaluation in201 cases with histopathological correlation[J].EurRadiol,2011,21(1):188-196.
  • 5Liu X,Zhou L,Peng W,et al.Differentiationof central gland prostate cancer from benignprostatic hyperplasia using monoexponential andbiexponential diffusion-weighted imaging[J].MagnReson Imaging,2013,31(8):1318-1324.
  • 6White NS,Dale AM.Distinct effects of nuclearvolume fraction and cell diameter on highb-value diffusion MRI contrast in tumors[J].MagnReson Med,2014,7(2):1435-1443.
  • 7Ohgiya Y,Suyama J,Seino N,et al.Diagnosticaccuracy of ultra-high-b-value 3.0-T diffusionweightedMR imaging for detection of prostate cancer[J].Clin Imaging,2012,36(5):526-531.
  • 8P a n g Y , T u r k b e y B , B e r n a r d o M , e t a l .Intravoxel incoherent motion MR imaging forprostate cancer:an evaluation of perfusion fractionand diffusion coefficient derived from differentb-value combinations[J].Magn Reson Med,2013,69(2):553-562.
  • 9Kitajima K,Takahashi S,Ueno Y,et al.Clinicalutility of apparent diffusion coefficient valuesobtained using high b-value when diagnosingprostate cancer using 3 tesla MRI:comparisonbetween ultra-high b-value(2000s/mm2)andstandard high b-value(1000 s/mm2)[J].J MagnReson Imaging,2012,36(1):198-205.
  • 10Nagel KN,Schouten MG,Hambrock T,et al.Differentiation of prostatitis and prostatec ance r by using diffusion-weighte d MRimaging and MR-guided biopsy at 3T[J].Radiology,2013,267(1):164-172.

二级参考文献15

  • 1Sershon PD,Barry MJ,Oesterling JE.Serum prostate-specific antigen discriminates weakly between men with benign prostatic byperplasia and patients with organ confined prostate cancer[J].Eur Uro1,1994,25(4):281 287.
  • 2Kang SH, Bae JH,Park HS,et al.Prostate-specific antigen adjusted for the transition zone volume as a second screening test.a prospective study of 248 cases[J].Int J Urol,2006,13(7)910- 914.
  • 3Kim KS,Jeong WS,Park SY,et al.The effect of two weeks of treatment with dutasteride on bleeding after transurethral resection of the prostate[J].World J Mens Health, 2015 , 33(1) :14- 19.
  • 4kuriyama M, Wang MC, Papsidero LD. Quantitation of Prostate specific antigen in serurm by a sensitive enzyme immunoassay[J].Cancer Res, 1980,40(12): 4658 -4662.
  • 5Bjork T,Piironen T,Pettersson K.Comparison of analysis of the different prostate specific antigen of in mrum for detection of clinically localized prostate cancer[J]. Urology, 1996,48(6); 8824 -888.
  • 6Stenman UH,Leinonen J,Alfthan H,et al.A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer:assay of the complex improves clinical sensitivity for cancer[J].Cancer Res, 1991, 51(1):222-226.
  • 7SEAMAN E,WHANG IS,OLSSON CA,et al. PSA density:role in patients evaluation and management[J]. Urol Clin N Am, 1993,20.653- 660.
  • 8Loeb S,Catalona WJ.Prostate specific antigen in clinical practice[J]. Cancer Lett, 2007,249(1): 30 -39.
  • 9Teoh JY,Tsu JH,Yuen SK,et al.Association of time to prostate-specific antigen nadir and logarithm of prostate-specific antigen velocity after progression in metastatic prostate cancer with prior primary androgen deprivation therapy[J]. Asian J Androl,2015,[Epub ahead of print].
  • 10Seikkula H,Pettersson K,Bostr6m PJ.PSA and blood test diagnostics of prostate cancer[J]. Duodecim, 2015,131(17}.- 1547-52.

共引文献10

同被引文献137

引证文献18

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部